Neuroprotectant for Hypertensive Intracerebral Hemorrhage
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Cattle encephalon glycoside and ignotin Cattle encephalon glycoside and ignotin (CEGI)
injection (drug approval H22025046; Jilin Sihuan Pharmaceutical Co. LTD., Jilin, People's
Republic of China) is a compound preparation of muscle extract from healthy rabbits and
cattle brain gangliosides, which was approved by the Chinese Food and Drug Administration in
2011 and was commonly used as neuroprotectant in the treatment of central and peripheral
nerve injuries in China. To evaluate the safety and efficacy of CEGI in treatment of
Hypertensive intracerebral hemorrhage, we designed this study.